FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)

57868 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
Hydrochlorothiazide and telmisartan only product Preferred (foundation metadata concept)
Hydrochlorothiazide only product Preferred (foundation metadata concept)
Hydrocoele fluid Acceptable (foundation metadata concept)
Hydrocortisone Preferred (foundation metadata concept)
Hydrocortisone (as hydrocortisone sodium succinate) 100 mg powder for solution for injection vial Preferred (foundation metadata concept)
Hydrocortisone (substance) Preferred (foundation metadata concept)
Hydrocortisone 1.67 mg/mL rectal suspension Preferred (foundation metadata concept)
Hydrocortisone 10 mg oral tablet Preferred (foundation metadata concept)
Hydrocortisone 20 mg oral tablet Preferred (foundation metadata concept)
Hydrocortisone 5 mg oral tablet Preferred (foundation metadata concept)
Hydrocortisone acetate Preferred (foundation metadata concept)
Hydrocortisone acetate (substance) Preferred (foundation metadata concept)
Hydrocortisone acetate 10 mg/g cutaneous cream Preferred (foundation metadata concept)
Hydrocortisone acetate 10 mg/g cutaneous ointment Preferred (foundation metadata concept)
Hydrocortisone acetate 25 mg rectal suppository Preferred (foundation metadata concept)
Hydrocortisone only product Preferred (foundation metadata concept)
Hydrocortisone sodium succinate Preferred (foundation metadata concept)
Hydrocortisone sodium succinate (substance) Preferred (foundation metadata concept)
Hydrolase Preferred (foundation metadata concept)
Hydrolase (disposition) Preferred (foundation metadata concept)
Hydromeningomyelocele Acceptable (foundation metadata concept)
Hydromorphone Preferred (foundation metadata concept)
Hydromorphone (substance) Preferred (foundation metadata concept)
Hydromorphone hydrochloride Preferred (foundation metadata concept)
Hydromorphone hydrochloride (substance) Preferred (foundation metadata concept)
Hydromorphone hydrochloride 1 mg oral tablet Preferred (foundation metadata concept)
Hydromorphone hydrochloride 1 mg/mL solution for injection Preferred (foundation metadata concept)
Hydromorphone hydrochloride 10 mg/mL solution for injection Preferred (foundation metadata concept)
Hydromorphone hydrochloride 2 mg oral tablet Preferred (foundation metadata concept)
Hydromorphone hydrochloride 2 mg/mL solution for injection Preferred (foundation metadata concept)
Hydromorphone hydrochloride 20 mg/mL solution for injection Preferred (foundation metadata concept)
Hydromorphone hydrochloride 3 mg oral tablet Preferred (foundation metadata concept)
Hydromorphone hydrochloride 4 mg oral tablet Preferred (foundation metadata concept)
Hydromorphone hydrochloride 4 mg/mL solution for injection Preferred (foundation metadata concept)
Hydromorphone hydrochloride 8 mg oral tablet Preferred (foundation metadata concept)
Hydromorphone only product Preferred (foundation metadata concept)
Hydromyelomeningocele Acceptable (foundation metadata concept)
Hydronephrosis Preferred (foundation metadata concept)
Hydronephrosis (disorder) Preferred (foundation metadata concept)
Hydroperitoneum Acceptable (foundation metadata concept)
Hydroperitonia Acceptable (foundation metadata concept)
Hydrophobia Acceptable (foundation metadata concept)
Hydrops Preferred (foundation metadata concept)
Hydrops (morphologic abnormality) Preferred (foundation metadata concept)
Hydrops abdominis Acceptable (foundation metadata concept)
Hydrosalpinx Preferred (foundation metadata concept)
Hydrosalpinx (disorder) Preferred (foundation metadata concept)
Hydrosyringomyelia Acceptable (foundation metadata concept)
Hydroureter Preferred (foundation metadata concept)
Hydroureter (disorder) Preferred (foundation metadata concept)
Hydroureteronephrosis Preferred (foundation metadata concept)
Hydroureteronephrosis (disorder) Preferred (foundation metadata concept)
Hydroxocobalamin Preferred (foundation metadata concept)
Hydroxocobalamin (as hydroxocobalamin acetate) 1 mg/mL solution for injection Preferred (foundation metadata concept)
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection Preferred (foundation metadata concept)
Hydroxocobalamin (substance) Preferred (foundation metadata concept)
Hydroxocobalamin acetate Preferred (foundation metadata concept)
Hydroxocobalamin acetate (substance) Preferred (foundation metadata concept)
Hydroxocobalamin chloride Preferred (foundation metadata concept)
Hydroxocobalamin chloride (substance) Preferred (foundation metadata concept)
Hydroxocobalamin only product Preferred (foundation metadata concept)
Hydroxycarbamide Acceptable (foundation metadata concept)
Hydroxycarbamide (substance) Preferred (foundation metadata concept)
Hydroxycarbamide 1 g oral tablet Acceptable (foundation metadata concept)
Hydroxycarbamide 200 mg oral capsule Acceptable (foundation metadata concept)
Hydroxycarbamide 300 mg oral capsule Acceptable (foundation metadata concept)
Hydroxycarbamide 400 mg oral capsule Acceptable (foundation metadata concept)
Hydroxycarbamide 500 mg oral capsule Acceptable (foundation metadata concept)
Hydroxycarbamide only product Acceptable (foundation metadata concept)
Hydroxychloroquine Preferred (foundation metadata concept)
Hydroxychloroquine (substance) Preferred (foundation metadata concept)
Hydroxychloroquine only product Preferred (foundation metadata concept)
Hydroxychloroquine sulfate Preferred (foundation metadata concept)
Hydroxychloroquine sulfate (substance) Preferred (foundation metadata concept)
Hydroxychloroquine sulfate 200 mg oral tablet Preferred (foundation metadata concept)
Hydroxydaunomycin hydrochloride Acceptable (foundation metadata concept)
Hydroxydaunorubicin hydrochloride Acceptable (foundation metadata concept)
Hydroxyurea Preferred (foundation metadata concept)
Hydroxyurea 1 g oral tablet Preferred (foundation metadata concept)
Hydroxyurea 200 mg oral capsule Preferred (foundation metadata concept)
Hydroxyurea 300 mg oral capsule Preferred (foundation metadata concept)
Hydroxyurea 400 mg oral capsule Preferred (foundation metadata concept)
Hydroxyurea 500 mg oral capsule Preferred (foundation metadata concept)
Hydroxyurea only product Preferred (foundation metadata concept)
Hymenoptera venom Preferred (foundation metadata concept)
Hymenoptera venom (substance) Preferred (foundation metadata concept)
Hyoscine Acceptable (foundation metadata concept)
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Acceptable (foundation metadata concept)
Hyoscine N butylbromide Acceptable (foundation metadata concept)
Hyoscine butylbromide Acceptable (foundation metadata concept)
Hyoscine butylbromide 20 mg/mL solution for injection Acceptable (foundation metadata concept)
Hyoscine hydrobromide Acceptable (foundation metadata concept)
Hyoscine hydrobromide 400 microgram/mL solution for injection Acceptable (foundation metadata concept)
Hyoscine hydrobromide 600 microgram/mL solution for injection Acceptable (foundation metadata concept)
Hyoscine only product Acceptable (foundation metadata concept)
Hyperactive behavior Preferred (foundation metadata concept)
Hyperactive behavior (finding) Preferred (foundation metadata concept)
Hyperactive bladder Acceptable (foundation metadata concept)
Hyperaldosteronism Preferred (foundation metadata concept)
Hyperalimentation Acceptable (foundation metadata concept)
Hyperalphalipoproteinemia Preferred (foundation metadata concept)

Start Previous Page 242 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start